Видео ютуба по тегу Merck Company

Merck CEO on Winrevair Approval, Obesity Drug, Health Costs
Merck CEO on Winrevair Approval, Obesity Drug, Health Costs
Merck Research Laboratories: The will to conquer the impossible
Merck Research Laboratories: The will to conquer the impossible
Кен Фрейзер, генеральный директор Merck & Co, Inc.
Кен Фрейзер, генеральный директор Merck & Co, Inc.
Обзор компании Merck. Индустрия производителей лекарств | Про Инвестиции
Обзор компании Merck. Индустрия производителей лекарств | Про Инвестиции
A conversation with Belén Garijo, CEO of Merck KGaA, Darmstadt, Germany
A conversation with Belén Garijo, CEO of Merck KGaA, Darmstadt, Germany
Merck vs. Abbvie: какие акции выбрать? Бизнес, финансы, перспективы / Инвест-Баттл
Merck vs. Abbvie: какие акции выбрать? Бизнес, финансы, перспективы / Инвест-Баттл
Merck Shifts Focus to Prescription Drugs, and More
Merck Shifts Focus to Prescription Drugs, and More
Merck & Co: Blockbuster Drugs - [Business Breakdowns, EP.189]
Merck & Co: Blockbuster Drugs - [Business Breakdowns, EP.189]
Merck & Co. Inc. success story | American multinational pharmaceutical company | Kenneth Frazier
Merck & Co. Inc. success story | American multinational pharmaceutical company | Kenneth Frazier
Merck - Impacting Life & Health With Science & Tech
Merck - Impacting Life & Health With Science & Tech
Merck CEO Robert Davis goes one-on-one with Jim Cramer
Merck CEO Robert Davis goes one-on-one with Jim Cramer
Merck CEO Robert Davis on Q3 results: Our portfolio sets us up for a good finish to the year
Merck CEO Robert Davis on Q3 results: Our portfolio sets us up for a good finish to the year
Merck & Co. (MRK): A Deep Dive into the Pharma Giant in Dow Joan's
Merck & Co. (MRK): A Deep Dive into the Pharma Giant in Dow Joan's
Обзор компании Merck & Company Inc.
Обзор компании Merck & Company Inc.
What Merck's treatment means for the company, vaccine makers
What Merck's treatment means for the company, vaccine makers
Акции Merck: стоит ли инвестировать? Финансы, дивиденды, мультипликаторы / Распаковка
Акции Merck: стоит ли инвестировать? Финансы, дивиденды, мультипликаторы / Распаковка
Mizuho's Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks
Mizuho's Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks
OncoImmune founder on Merck acquiring the company to ramp up supply of Covid-19 drug
OncoImmune founder on Merck acquiring the company to ramp up supply of Covid-19 drug
Spotlight: Steven Hildemann, SVP at Merck Healthcare
Spotlight: Steven Hildemann, SVP at Merck Healthcare
Merck overview - Обзор компании Merck
Merck overview - Обзор компании Merck